Cracking the Code of Bacterial Division: How Understanding Cell Division Can Lead to New Antibiotics
"A new study reveals how cell division in Corynebacterium works, offering hope for fighting antibiotic-resistant infections."
In an era where antibiotic resistance is rapidly increasing, the need for new therapeutic strategies is more critical than ever. Pathogenic bacteria are evolving to resist existing antibiotics, causing a range of serious diseases that are increasingly difficult to treat. This challenge has spurred researchers to explore innovative approaches, focusing on the fundamental processes that allow bacteria to thrive and spread.
One promising area of research is bacterial cell division, a complex process essential for bacterial survival and propagation. Understanding the intricacies of cell division can reveal vulnerabilities that can be targeted with new drugs. A recent study delves into the cell division mechanisms of the Corynebacterium genus, a group of bacteria known for both its medical and biotechnological importance.
Corynebacterium includes species that cause diseases like diphtheria and pseudotuberculosis, making it a key target for new antibacterial strategies. This research focuses on the proteins involved in cell division, particularly SepF and FtsZ, and their interactions. By examining how these proteins function and interact, scientists hope to identify novel targets for therapeutic intervention.
The Rising AMR Burden
The CDC reported on February 4, 2025, that six bacterial antimicrobial-resistant hospital-onset infections increased by a combined 20% during the COVID-19 pandemic compared with the pre-pandemic period, peaking in 2021 and remaining above pre-pandemic levels. CDC's NARMS reports and interactive dashboards track antimicrobial resistance among enteric bacteria, including isolate types, resistance patterns, and trends. The WHO describes antimicrobial resistance as a threat to modern medicine and to an effective global public health response to infectious diseases.
A Longstanding Challenge
Antimicrobial resistance has affected infectious-disease treatment since the first modern antimicrobials were discovered, according to a historical review. Antibiotics revolutionized medicine and saved countless lives after their discovery in the early 20th century, but resistance has increasingly overshadowed those achievements. Reviews of resistance history emphasize that bacterial adaptation, including genetic and biochemical changes across many aspects of cell function, has been central to the problem.
Why Understanding Bacterial Cell Division Matters
Bacterial cell division, also known as divisome, in Corynebacterium involves a complex machinery of conserved proteins. This process is essential for bacteria to multiply and cause infections. The divisome assembly requires the cooperative recruitment of cell division proteins, initiated by the highly conserved tubulin homolog FtsZ. This process occurs in two main steps:
- Late divisome components facilitate lateral interaction between protofilaments, forming stable bundles.
- FtsZ interacts dynamically with many cytosolic molecules and must be precisely timed and placed for cell division.
Targeting Division
Research on Mycobacterium tuberculosis has identified agents that target the interaction between the bacterial division proteins FtsZ and SepF. The compound T0349 was reported to inhibit bacterial cell division by inducing filamentation and an abnormal septum. Broader reviews describe antibiotic action through four distinct mechanisms while noting that resistance has become a major challenge to treating bacterial infections.
Biological Complexity
Research on cell division in Corynebacterium found many conserved proteins associated with the division process, but did not observe FtsA and ZapA, which interact with FtsZ. This finding indicates that division machinery may not be uniform across bacterial groups, complicating efforts to apply one division-targeting strategy broadly. In addition, bacteria can resist antibiotics by altering drug targets, producing drug-inactivating enzymes, or exporting drugs through efflux systems, with resistance promoted by mutation, horizontal gene transfer, and antibiotic misuse.
Looking Ahead: Novel Therapeutic Targets
This research highlights the potential of targeting the interaction between FtsZ and SepF as a new therapeutic strategy. The study also identified new protein candidates that could be further explored as drug targets to control bacterial infections. By combining in silico and in vitro analyses, scientists are gaining a more complete understanding of cell division in bacteria, paving the way for the development of new and effective antibiotics.
Beyond Conventional Resistance
Recent perspectives distinguish antibiotic resistance from tolerance by examining how bacterial populations respond to antibiotic exposure. A 2026 review argues that the stagnation of novel antibiotic discovery makes mechanism-based innovation increasingly important and links antibiotic mechanisms with bacterial resistance pathways. Whole-cell modeling also suggests that bacteria can change their shapes to improve fitness during antibiotic exposure, potentially working alongside other resistance pathways.
Resistance in Real Communities
The real-world dynamics of antimicrobial resistance depend on both the fitness effects of resistance genes and antibiotic pressure in bacterial populations. The burden imposed by resistance varies with the specific mutation: some mutations substantially reduce bacterial growth, while others have little effect. Cell-division research offers a possible complementary approach, with work on Helicobacter pylori suggesting that preventing chromosomes from untangling could help inform new treatments as antibiotic resistance rises.